Outset Medical (OM) Shares Down 94% Since Disclosing FDA Warning Letter, Morgan Stanley And JPMorgan Chase Unload Most Of Their Positions In OM Shares - Hagens Berman SAN FRANCISCO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (NASDAQ: OM) is facing a perilous situation as it grapples with a potential delisting from the Nasdaq and a class-action lawsuit...

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Outset Medical (OM) Investors with Over $300,000 Losses to Contact the Firm’s Attorneys Before Sept. 6th Deadline in Securities Fraud Class Action SAN FRANCISCO, Aug. 29, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Outset Medical, Inc. (NASDAQ: OM) investors who have suffered over $300,000 losses to submit your losses now. Class Period: Sept....

OM 13-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Outset Medical (OM) Investors with Over $300,000 Losses to Contact the Firm’s Attorneys Before Sept. 6th Deadline in Securities Fraud Class Action SAN FRANCISCO, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Outset Medical, Inc. (NASDAQ: OM) investors who have suffered over $300,000 losses to submit your losses now. Class Period: Sept....

OM INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Outset Medical (OM) Investors with Over $300,000 Losses to Contact the Firm’s Attorneys, Securities Fraud Class Action Pending SAN FRANCISCO, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Outset Medical, Inc. (NASDAQ: OM) investors who have suffered over $300,000 losses to submit your losses now. Class Period: Sept....

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Outset Medical (OM) Investors with Over $300,000 Losses to Contact the Firm’s Attorneys, Securities Fraud Class Action Pending SAN FRANCISCO, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Outset Medical, Inc. (NASDAQ: OM) investors who have suffered over $300,000 losses to submit your losses now. Class Period:...